First targeted therapy in multiple myeloma

Kortuem KM, Einsele H (2017)

Publication Type: Journal article

Publication year: 2017

Journal

Blood American Society of Hematology

Book Volume: 130

Pages Range: 2359-2360

Journal Issue: 22

DOI: 10.1182/blood-2017-09-805341

Abstract

In this issue of Blood, Kumar et al and Moreau et al both report venetoclax to be safe and effective in the treatment of multiple myeloma (MM), the second most common hematological malignancy.1,2

Involved external institutions

Universitätsklinikum Würzburg DE Germany (DE)

How to cite

APA:

Kortuem, K.M., & Einsele, H. (2017). First targeted therapy in multiple myeloma. Blood, 130(22), 2359-2360. https://doi.org/10.1182/blood-2017-09-805341

MLA:

Kortuem, K. Martin, and Hermann Einsele. "First targeted therapy in multiple myeloma." Blood 130.22 (2017): 2359-2360.

BibTeX: Download